Toggle navigation
Catalyst Capital
Home
About
Overview
Guiding Principles
Community
Case Studies
Awards & Recognition
Our Team
Portfolio
News
Contact Us
Investor Login
News
Evolve Biologics™ Reaches Major Milestones in Phase III Trial for PlasmaCap™ IG (Intravenous Immunoglobulin), Including Dosing of First Pediatric Patient
May 2018
/ Author: elissa
May 4, 2018 – Business Wire